Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients

NCT02531412 is registered in ClinicalTrials.gov with Instituto Nacional de Cancerologia de Mexico as lead sponsor.

NCT NCT02531412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02531412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients
Lead sponsor
Instituto Nacional de Cancerologia de Mexico
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2015
Completion date
September 30, 2017
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, critically ill